BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 19531934)

  • 1. The effect of time to antifungal therapy on mortality in Candidemia associated septic shock.
    Patel GP; Simon D; Scheetz M; Crank CW; Lodise T; Patel N
    Am J Ther; 2009; 16(6):508-11. PubMed ID: 19531934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Septic shock attributed to Candida infection: importance of empiric therapy and source control.
    Kollef M; Micek S; Hampton N; Doherty JA; Kumar A
    Clin Infect Dis; 2012 Jun; 54(12):1739-46. PubMed ID: 22423135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.
    Garey KW; Rege M; Pai MP; Mingo DE; Suda KJ; Turpin RS; Bearden DT
    Clin Infect Dis; 2006 Jul; 43(1):25-31. PubMed ID: 16758414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
    Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
    J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital resource utilization and costs of inappropriate treatment of candidemia.
    Arnold HM; Micek ST; Shorr AF; Zilberberg MD; Labelle AJ; Kothari S; Kollef MH
    Pharmacotherapy; 2010 Apr; 30(4):361-8. PubMed ID: 20334456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluconazole improves survival in septic shock: a randomized double-blind prospective study.
    Jacobs S; Price Evans DA; Tariq M; Al Omar NF
    Crit Care Med; 2003 Jul; 31(7):1938-46. PubMed ID: 12847386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
    Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
    Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.
    Degoricija V; Sharma M; Legac A; Gradiser M; Sefer S; Vucicević Z
    Croat Med J; 2006 Jun; 47(3):385-97. PubMed ID: 16758516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients.
    Davis SL; Vazquez JA; McKinnon PS
    Ann Pharmacother; 2007 Apr; 41(4):568-73. PubMed ID: 17374623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Before-after study of a standardized hospital order set for the management of septic shock.
    Micek ST; Roubinian N; Heuring T; Bode M; Williams J; Harrison C; Murphy T; Prentice D; Ruoff BE; Kollef MH
    Crit Care Med; 2006 Nov; 34(11):2707-13. PubMed ID: 16943733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiologic analysis and antifungal susceptibility of Candida blood isolates in southern Taiwan.
    Chen TC; Chen YH; Tsai JJ; Peng CF; Lu PL; Chang K; Hsieh HC; Chen TP
    J Microbiol Immunol Infect; 2005 Jun; 38(3):200-10. PubMed ID: 15986071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of septic shock hemodynamic resuscitation guidelines on rapid early volume replacement and reduced mortality.
    Permpikul C; Tongyoo S; Ratanarat R; Wilachone W; Poompichet A
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S102-9. PubMed ID: 20364564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time- and fluid-sensitive resuscitation for hemodynamic support of children in septic shock: barriers to the implementation of the American College of Critical Care Medicine/Pediatric Advanced Life Support Guidelines in a pediatric intensive care unit in a developing world.
    Oliveira CF; Nogueira de Sá FR; Oliveira DS; Gottschald AF; Moura JD; Shibata AR; Troster EJ; Vaz FA; Carcillo JA
    Pediatr Emerg Care; 2008 Dec; 24(12):810-5. PubMed ID: 19050666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory response and clinical course of adult patients with nosocomial bloodstream infections caused by Candida spp.
    Wisplinghoff H; Seifert H; Wenzel RP; Edmond MB
    Clin Microbiol Infect; 2006 Feb; 12(2):170-7. PubMed ID: 16441456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes.
    Grim SA; Berger K; Teng C; Gupta S; Layden JE; Janda WM; Clark NM
    J Antimicrob Chemother; 2012 Mar; 67(3):707-14. PubMed ID: 22184469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality.
    Morrell M; Fraser VJ; Kollef MH
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3640-5. PubMed ID: 16127033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections.
    Parkins MD; Sabuda DM; Elsayed S; Laupland KB
    J Antimicrob Chemother; 2007 Sep; 60(3):613-8. PubMed ID: 17576697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blind, placebo-controlled trial of granulocyte colony-stimulating factor in patients with septic shock.
    Stephens DP; Thomas JH; Higgins A; Bailey M; Anstey NM; Currie BJ; Cheng AC
    Crit Care Med; 2008 Feb; 36(2):448-54. PubMed ID: 18216600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.